.@US_FDA's 2017 generic drug approvals contributed to prescription drug buyers saving $8.8 billion. These dramatic savings were driven in part because FDA set multiple approval records in 2017, including the most generic drugs approved in a year. pic.twitter.com/PgNAgPSf9W